Toxicogenomics in drug discovery: from preclinical studies to clinical trials

MLA

Yang, Yi, et al. “Toxicogenomics in Drug Discovery: From Preclinical Studies to Clinical Trials.” Chemico-Biological Interactions, vol. 150, no. 1, Nov. 2004, pp. 71–85. EBSCOhost, https://doi.org/10.1016/j.cbi.2004.09.013.

APA

Yang, Y., Blomme, E. A. G., & Waring, J. F. (2004). Toxicogenomics in drug discovery: from preclinical studies to clinical trials. Chemico-Biological Interactions, 150(1), 71–85. https://doi.org/10.1016/j.cbi.2004.09.013

Chicago

Yang, Yi, Eric A.G. Blomme, and Jeffrey F. Waring. 2004. “Toxicogenomics in Drug Discovery: From Preclinical Studies to Clinical Trials.” Chemico-Biological Interactions 150 (1): 71–85. doi:10.1016/j.cbi.2004.09.013.